Cetuximab Plus Capecitabine and Irinotecan Compared With Cetuximab Plus Capecitabine and Oxaliplatin As First-Line Treatment for Patients With Metastatic Colorectal Cancer: AIO KRK-0104--A Randomized Trial of the German AIO CRC Study Group

✍ Scribed by Moosmann, N.; von Weikersthal, L. F.; Vehling-Kaiser, U.; Stauch, M.; Hass, H. G.; Dietzfelbinger, H.; Oruzio, D.; Klein, S.; Zellmann, K.; Decker, T.; Schulze, M.; Abenhardt, W.; Puchtler, G.; Kappauf, H.; Mittermuller, J.; Haberl, C.; Schalhorn, A.; Jung, A.; Stintzing, S.; Heinemann, V.

• Book ID: 121758353
• Publisher: American Society of Clinical Oncology
• Year: 2011
• Tongue: English
• Weight: 169 KB
• Volume: 29
• Category: Article
• ISSN: 0732-183X
• DOI: 10.1200/JCO.2010.31.1936